Davis Chaim 5

5 · AMERICAN BIO MEDICA CORP · Filed Jan 8, 2020

Form 5

Period: 2019-12-31

Director

Transactions

Award
Common Shares
2018-06-21$0.10/sh+33,784$3,378→ 58,507 total
Purchase
Common Shares
2019-01-23$0.10/sh+500,000$50,000→ 2,449,915 total(indirect: By Revach Fund, LP)
Award
Common Shares
2018-10-15$0.09/sh+35,036$3,153→ 93,543 total
Award
Common Shares
2019-10-10$0.09/sh+37,398$3,366→ 197,349 total
Other
Non-Statutory Stock Option
2013-04-26$0.18/sh+50,000$9,000→ 50,000 total
Exercise: $0.18From: 2014-04-26Exp: 2023-04-26→ Common Shares (50,000 underlying)
Other
Non-Statutory Stock Option
2019-06-20$0.07/sh+20,000$1,400→ 20,000 total
Exercise: $0.07From: 2020-06-20Exp: 2029-06-20→ Common Shares (20,000 underlying)
Award
Common Shares
2019-01-23$0.08/sh+38,993$3,119→ 132,536 total
Award
Common Shares
2019-06-20$0.07/sh+27,415$1,919→ 159,951 total
Other
Non-Statutory Stock Option
2018-06-21$0.10/sh+20,000$2,000→ 20,000 total
Exercise: $0.10From: 2019-06-21Exp: 2028-06-21→ Common Shares (20,000 underlying)

Footnotes (2)

[F1]Previously reported on Form 4.
[F2]The common shares are in the name of Revach Fund, LP. The reporting person (Davis) is a managing member of Revach Group, LLC which operates as the general partner for the Revach Fund, LP.

Documents

1 file